| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | -0.075 | 0.07 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | -0.062 | 0.07 |
| mRNA | AT-7519 | GDSC1000 | pan-cancer | AAC | -0.059 | 0.08 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | -0.073 | 0.08 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | -0.063 | 0.08 |
| mRNA | piperlongumine | GDSC1000 | pan-cancer | AAC | 0.065 | 0.08 |
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | -0.062 | 0.08 |
| mRNA | Doxorubicin | FIMM | pan-cancer | AAC | 0.24 | 0.08 |
| mRNA | GDC-0449 | GDSC1000 | pan-cancer | AAC | 0.074 | 0.08 |
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | 0.17 | 0.08 |